Peran Kepuasan Hidup dalam Pengelolaan Penyakit Systemic Sclerosis

Helsa Nasution; M. Agung Rahmadi; Luthfiah Mawar; Ika Sandra Dewi; Romaito Nasution; Milna Sari

doi:10.55606/termometer.v2i4.4359

Authors

Helsa Nasution Universitas Negeri Padang
M. Agung Rahmadi Universitas Islam Negeri Syarif Hidayatullah Jakarta
Luthfiah Mawar Universitas Sumatera Utara
Ika Sandra Dewi Universitas Muslim Nusantara Al-Washliyah
Romaito Nasution Universitas Islam Negeri Sumatera Utara
Milna Sari Universitas Islam Negeri Sumatera Utara

DOI:

https://doi.org/10.55606/termometer.v2i4.4359

Keywords:

life satisfaction, disease management, systemic sclerosis

Abstract

This study examines life satisfaction's role in managing Systemic Sclerosis (SSc) through a comprehensive meta-analysis. Out of 1,247 identified articles, 42 studies met the inclusion criteria, encompassing 8,734 SSc patients. The findings reveal a significant positive correlation between life satisfaction and treatment adherence in Systemic Sclerosis (r = 0.39, 95% CI [0.32, 0.45], p < 0.001), utilizing adaptive coping strategies (r = 0.45, 95% CI [0.38, 0.51], p < 0.001). Additionally, life satisfaction was negatively correlated with depression (r = -0.52, 95% CI [-0.58, -0.45], p < 0.001) and anxiety (r = -0.47, 95% CI [-0.54, -0.39], p < 0.001). Social support emerged as a strong predictor of life satisfaction (r = 0.51, 95% CI [0.44, 0.57], p < 0.001). Furthermore, interventions aimed at enhancing life satisfaction demonstrated a significant positive effect (d = 0.62, 95% CI [0.45, 0.79], p < 0.001). Moderator analyses indicated that age and disease duration influenced the strength of the relationship between life satisfaction and SSc management. The researchers believe these findings extend previous studies by Kwakkenbos et al. (2015) and Malcarne et al. (2013) by quantifying the strength of the relationship between life satisfaction and various aspects of SSc management on a larger scale. Unlike the findings of Thombs et al. (2010), which focused primarily on depression, this study provides a broader perspective on the role of life satisfaction in SSc. Consequently, these results support the integration of life satisfaction assessment and interventions in SSc care, emphasizing the importance of a more comprehensive biopsychosocial approach. Finally, the researchers acknowledge limitations in this study, including high heterogeneity (I² = 62-78%) and potential publication bias. Future research should focus on longitudinal studies and the development of targeted interventions to enhance life satisfaction in SSc patients.

Downloads

Download data is not yet available.

References

Allanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015). Systemic sclerosis. Nature Reviews Disease Primers, 1(1), 1-21.

Barnes, J., & Mayes, M. D. (2012). Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Current Opinion in Rheumatology, 24(2), 165–170.

Baubet, T., Ranque, B., Taïeb, O., Bérezné, A., Bricou, O., Mehallel, S., ... & Mouthon, L. (2011). Mood and anxiety disorders in systemic sclerosis patients. La Presse Médicale, 40(2), e111-e119.

Boehm, J. K., & Kubzansky, L. D. (2012). The heart's content: the association between positive psychological well-being and cardiovascular health. Psychological Bulletin, 138(4), 655.

Chularojanamontri, L., Sethabutra, P., Kulthanan, K., & Manapajon, A. (2011). Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study. Indian Journal of Dermatology, Venereology and Leprology, 77, 683.

Cigolini, B. (2022). Molecular profiling longitudinale per decifrare i meccanismi di risposta immunitaria ai vaccini a mRNA contro SARS-CoV-2 in soggetti sani ed in pazienti oncologici.

Cohen, S. (2004). Social relationships and health. American Psychologist, 59(8), 676.

De Ridder, D., Geenen, R., Kuijer, R., & Van Middendorp, H. (2008). Psychological adjustment to chronic disease. The Lancet, 372(9634), 246-255.

Denton, C. P., & Khanna, D. (2017). Systemic sclerosis. The Lancet, 390(10103), 1685–1699.

Diener, E., & Chan, M. Y. (2011). Happy people live longer: Subjective well‐being contributes to health and longevity. Applied Psychology: Health and Well‐Being, 3(1), 1-43.

Diener, E. D., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49(1), 71-75.

Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 196(4286), 129–136.

Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacology Bulletin, 29(2), 321–326.

Feinstein, A. R. (1987). Clinimetrics. Yale University Press.

Fingeret, M. C., Teo, I., & Epner, D. E. (2014). Managing body image difficulties of adult cancer patients: Lessons from available research. Cancer, 120(5), 633-641.

Fredrickson, B. L. (2001). The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions. American Psychologist, 56(3), 218.

Gholizadeh, S., Fox, R. S., Mills, S. D., Jewett, L. R., Thombs, B. D., & Malcarne, V. L. (2017). Coping with the disfigurement of scleroderma: Facial, skin, and hand changes. Scleroderma: From Pathogenesis to Comprehensive Management, 713-721.

Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychology and Health, 18(2), 141–184.

Haythornthwaite, J. A., Heinberg, L. J., & McGuire, L. (2003). Psychologic factors in scleroderma. Rheumatic Disease Clinics, 29(2), 427–439.

Herrick, A. L. (2017). Therapeutic implications from the pathogenesis of Raynaud’s phenomenon. Expert Review of Clinical Immunology, 13(7), 723–735.

Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., ... & Sterne, J. A. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ, 343.

Hudson, M., Thombs, B. D., Steele, R., Panopalis, P., Newton, E., Baron, M., & Canadian Scleroderma Research Group. (2009). Health‐related quality of life in systemic sclerosis: A systematic review. Arthritis Care & Research, 61(8), 1112–1120.

Jewett, L. R., Hudson, M., Malcarne, V. L., Baron, M., Thombs, B. D., & Canadian Scleroderma Research Group. (2012). Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PloS One, 7(3), e33281.

Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., ... & Müller-Ladner, U. (2017). Update of EULAR recommendations for the treatment of systemic sclerosis. Annals of the Rheumatic Diseases, 76(8), 1327-1339.

Kwakkenbos, L., Delisle, V. C., Fox, R. S., Gholizadeh, S., Jewett, L. R., Levis, B., ... & Thombs, B. D. (2015). Psychosocial aspects of scleroderma. Rheumatic Disease Clinics, 41(3), 519-528.

Leventhal, H., Phillips, L. A., & Burns, E. (2016). The Common-Sense Model of Self-Regulation (CSM): A dynamic framework for understanding illness self-management. Journal of Behavioral Medicine, 39, 935–946.

Luyster, F. S., Hughes, J. W., & Gunstad, J. (2009). Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator. Journal of Cardiovascular Nursing, 24(1), 10–17.

Malcarne, V. L., Fox, R. S., Mills, S. D., & Gholizadeh, S. (2013). Psychosocial aspects of systemic sclerosis. Current Opinion in Rheumatology, 25(6), 707–713.

Mouthon, L., Alami, S., Boisard, A. S., Chaigne, B., Hachulla, E., & Poiraudeau, S. (2017). Patients’ views and needs about systemic sclerosis and its management: A qualitative interview study. BMC Musculoskeletal Disorders, 18(1), 1-10.

Neugarten, B. L., Havighurst, R. J., & Tobin, S. S. (1961). The measurement of life satisfaction. Journal of Gerontology.

Nguyen, C., Ranque, B., Baubet, T., Bérezné, A., Mestre-Stanislas, C., Rannou, F., ... & Groupe Français de Recherche sur la Sclérodermie. (2014). Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: A cross-sectional survey. PloS One, 9(2), e90484.

Pattanaik, D., Brown, M., & Postlethwaite, A. E. (2011). Vascular involvement in systemic sclerosis (scleroderma). Journal of Inflammation Research, 4, 105–125.

Peterson, J., Welch, V., Losos, M., & Tugwell, P. J. (2011). The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute, 2(1), 1-12.

Polonsky, W. H., Fisher, L., Hessler, D., & Edelman, S. V. (2014). What is so tough about self‐monitoring of blood glucose? Perceived obstacles among patients with type 2 diabetes. Diabetic Medicine, 31(1), 40-46.

Poole, J. L., & Steen, V. D. (1991). The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care & Research, 4(1), 27–31.

Schieir, O., Thombs, B. D., Hudson, M., Taillefer, S. S., & Baron, M. (2010). Prevalence and clinical correlates of posttraumatic stress disorder in systemic sclerosis: A mental health surveillance study. Arthritis Care & Research, 62(8), 1198–1204.

Serge, A. (2019). La sclérose systémique. Doin Éditeurs.

Taylor, S. E. (2011). Social support: A review. The Oxford Handbook of Health Psychology, 189-214.

Thombs, B. D., Hudson, M., Schieir, O., Taillefer, S. S., Baron, M., & Canadian Scleroderma Research Group. (2008). Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Care & Research, 59(3), 438–443.

Trombetta, A. C., Smith, V., Parodi, A., Damonte, G., Paolino, S., Sulli, A., ... & Cutolo, M. (2016). Altered toll-like receptor 4 expression and vascular inflammation in systemic sclerosis. Journal of Rheumatology, 43(6), 1068–1074.

Van Lankveld, W., Vonk, M., Teunissen, H., & van den Hoogen, F. (2007). Appearance self-esteem in systemic sclerosis–subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology, 46(5), 872-876.

Williams, H., & Stern, R. (2022). Risk factors in systemic sclerosis. The Journal of Rheumatology, 49(5), 457–468.